Mediwound Ltd share price logo

Mediwound Ltd Share Price

NASDAQ: MDWD

Small Cap

$18.79

-0.68

(-3.49%)

as on

Mediwound Ltd Stock Performance

as on October 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $18.32
    $19.48
    downward going graph

    2.50%

    Downside

    3.67%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $14.14
    $22.51
    downward going graph

    24.75%

    Downside

    19.77%

    Upside

    downward going graph

Mediwound Ltd share price movements today

Previous Close
$19.47
Open
$19.32
Volume
183.5K
Day's Low - High
$18.32 - $19.48
52 Week Low - High
$14.14 - $22.51

Mediwound Ltd Historical Returns

1 Month Return
+ 8.96 %
3 Month Return
-8.14 %
1 Year Return
+ 6.91 %
3 Year Return
+ 85.17 %
5 Year Return
-26.44 %

Mediwound Ltd Stock Fundamentals & Key Indicators

Check Mediwound Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$249.6M

EPS (TTM)

-2.896

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-8.47

Industry PE ratio

0

PEG Ratio

-0.07

EBITDA

-21.3M

Revenue (TTM)

19.9M

Profit Margin

-142.18%

Return On Equity TTM

124202700.00%

Mediwound Ltd Stock Valuation

Track how Mediwound Ltd P/E has moved over time to understand its valuation trends.

Mediwound Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-15.23x)

March 31, 2021

Industry (0.00x)

October 18, 2025

Today (-8.47x)

October 18, 2025

Highest (-2.68x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -8.47x

Mediwound Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mediwound Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$249.6M-26.44%-8.47-142.18%
BUY$63.1B231.27%-505.15-12.96%
NA$36.7BNANA-3.89%
BUY$104.8B91.13%29.0431.86%
BUY$60.3B-3.62%14.3531.37%

Stock Returns calculator for Mediwound Ltd Stock including INR - Dollar returns

The Mediwound Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Mediwound Ltd investment value today

Current value as on today

₹1,11,677

Returns

₹11,677

(+11.68%)

Returns from Mediwound Ltd Stock

₹6,883 (+6.88%)

Dollar Returns*

₹4,794 (+4.79%)

Analyst Recommendation on Mediwound Ltd Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Mediwound Ltd. Average target price of $30.67

Mediwound Ltd Share Price Target

Get share price movements and forecasts by analysts on Mediwound Ltd.

What analysts predicted

38.73%UPSIDE

Target Price

$30.67

Current Price

$18.79

Analyzed by

10 Analysts

Target

$30.67

Mediwound Ltd target price $30.67, a slight upside of 38.73% compared to current price of $18.79. According to 10 analysts rating.

Mediwound Ltd Stock’s Investor Sentiment and Interest

Search interest for Mediwound Ltd Stock has increased by 133% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:133% versus previous 30 day period

Mediwound Ltd Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
3
4
4
5
4
5
4
5
3
5
Gross Profit
0
1
0
0
0
0
0
0
0
1
Operating Income
-4
-4
-3
-3
-3
-4
-5
-6
-5
-5
EBITDA
-4
-3
-2
-1
-3
-4
-4
-15
-4
-5
Interest Expense
0
0
-
5
5
2
5
-
-
7
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
0
-2
-1
-9
-6
-10
-3
0
-13
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-3
0
-2
-1
-9
-6
-10
-3
0
-13
Net Profit Margin
-97.21%
19.19%
-45.98%
-32.65%
-195.99%
-124.53%
-236.10%
-66.92%
-18.36%
-233.32%

Mediwound Ltd Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
1
2
3
31
21
23
26
18
20
Gross Profit
-1
0
0
1
19
7
8
13
3
2
Operating Income
-21
-20
-13
-3
4
-8
-11
-8
-15
-19
EBITDA
-20
-18
-13
-4
4
-7
-11
-18
-4
-28
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
-
-
0
0
1
1
1
1
1
1
Income Before Tax
-21
-18
-14
-5
2
-9
-13
-19
-6
-30
Income Tax Expense
0
-1
8
-9
-1
0
0
0
0
0
Net Income
-22
-18
-22
-1
4
-9
-13
-19
-6
-30
Net Profit Margin
-3675.21%
-1212.13%
-887.38%
-31.08%
15.59%
-42.26%
-57.03%
-73.97%
-35.94%
-149.46%

Mediwound Ltd Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
0
-2
-1
-9
-6
-10
-3
0
-13
Operating Cash Flow
-5
-3
-1
-4
-3
-3
-1
-4
-5
Investing Cash Flow
-26
-5
4
-2
2
-14
4
-3
4
Financing Cash Flow
0
0
0
0
0
20
0
0
0
Change in Cash
-31
-9
2
23
0
2
2
-7
0

Mediwound Ltd Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-18
-22
-1
4
-9
-13
-19
-6
-30
Operating Cash Flow
-16
-16
-12
8
-6
-8
-11
-10
-13
Investing Cash Flow
1
0
-17
-6
17
3
0
-34
-8
Financing Cash Flow
0
22
0
-1
0
-1
35
22
19
Change in Cash
-13
7
-29
0
10
-6
22
-22
-2

Global Institutional Holdings in Mediwound Ltd

Funds
Holdings
Investors Finance Co PLC
8.02%
Yelin Lapidot Holdings Management Ltd
7.51%
BlackRock Inc
3.96%
Rosalind Advisors, Inc.
3.74%
T. Rowe Price Associates, Inc.
3.45%

Insights on Mediwound Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 3.95M → 5.70M (in $), with an average increase of 30.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, MDWD stock has moved up by 9.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.8% return, outperforming this stock by 55.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 148.2% return, outperforming this stock by 63.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -726.0K → -13.31M (in $), with an average decrease of 1734.4% per quarter

About Mediwound Ltd

mediwound is a fully-integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel therapeutics based on its patented proteolytic enzyme technology to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds. mediwound’s first innovative biopharmaceutical product, nexobrid®, received marketing authorization from the european medicines agency as well as the israeli and argentinian ministries of health, for removal of dead or damaged tissue, known as eschar, in adults with deep partial and full-thickness thermal burns and was launched in europe israel and argentina. nexobrid represents a new paradigm in burn care management, and clinical trials have demonstrated, with statistical significance, its ability to non-surgically and rapidly remove the eschar earlier and without harming viable tissue. mediwound's second innovative product, escharex®, is a topical biological drug being developed for debridement of chronic and
OrganisationMediwound Ltd
Headquarters42 Hayarkon Street, Yavne, Israel, 8122745
IndustryHealth Technology
CEOMr. Ofer Gonen B.Sc.
E-voting on sharesClick here to vote

Key Management of Mediwound Ltd

Name

Title

Ms. Hani Luxenburg

Chief Financial Officer

Dr. Shmulik Hess Ph.D.

COO & Chief Commercial Officer

Mr. Yaron Meyer Adv.

Executive VP, General Counsel & Corporate Secretary

Dr. Ety Klinger MBA, Ph.D.

Chief Research & Development Officer

Mr. Barry J. Wolfenson

Executive Vice President of Strategy & Corporate Development

Ms. Hagit Mashiach

VP of Human Resources

Dr. Robert J. Snyder CWS, D.P.M., F.A.C.F.A.S., FFPM, M.B.A., M.Sc.

Chief Medical Officer

Mr. Ofer Gonen B.Sc.

Chief Executive Officer

FAQs

What is Mediwound Ltd share price today?

Mediwound Ltd share price today is $18.79 as on at the close of the market. Mediwound Ltd share today touched a day high of $19.48 and a low of $18.32.

What is the 52 week high and 52 week low for Mediwound Ltd share?

Mediwound Ltd share touched a 52 week high of $22.51 on and a 52 week low of $14.14 on . Mediwound Ltd stock price today i.e. is closed at $18.79,which is 16.51% down from its 52 week high and 32.89% up from its 52 week low.

What is Mediwound Ltd's market capitalisation today?

Mediwound Ltd market capitalisation is $0.00T as on .

How to invest in Mediwound Ltd Stock (MDWD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Mediwound Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mediwound Ltd Shares that will get you 0.0798 shares as per Mediwound Ltd share price of $18.79 per share as on October 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Mediwound Ltd Stock (MDWD) from India?

Indian investors can start investing in Mediwound Ltd (MDWD) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Mediwound Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Mediwound Ltd share’s latest price of $18.79 as on October 18, 2025 at 1:29 am IST, you will get 0.5322 shares of Mediwound Ltd. Learn more about fractional shares .

What are the returns that Mediwound Ltd has given to Indian investors in the last 5 years?

Mediwound Ltd stock has given -26.44% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?